Search Results - "Spring LM"

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.

Authors: Spring LM Han H Liu MC et al.

Source: Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE

Selection biases in the systematic collection of breast biobank specimens.

Authors: Bar Y Wang GX Gioia GE et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Aug 01; Vol. 11 (1), pp. 83. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Uncovering the mechanisms of synergistic drug combinations in non-small cell lung cancer through metagene-based classification.

Authors: Lomloy, Comkrit Yamashita, Piyanut Ratphibun Termsaithong, Teerasit et al.

Source: PLoS ONE. 5/12/2026, Vol. 21 Issue 5, p1-21. 21p.

Residual cancer burden following neoadjuvant chemotherapy in breast cancer: A retrospective analysis by receptor subtype.

Authors: Khan, Monalisa Gupta, Rahul Soni, Satyajeet et al.

Source: Cancer Research, Statistics & Treatment. Apr-Jun2026, Vol. 9 Issue 2, p102-107. 6p.

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Authors: Spring LM Scarpetti L Medford AJ et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jan 07; Vol. 11 (1), pp. 2. Date of Electronic Publication: 2025 Jan 07.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Authors: Zhang, Jian Meng, Yanchun Wang, Biyun et al.

Source: PLoS Medicine. 7/31/2025, Vol. 22 Issue 7, p1-17. 17p.

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

Authors: Wander SA Lloyd MR Keenan JC et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 May; Vol. 27 (5), pp. 580-591.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

Authors: Wu B Thant W Bitman E et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Apr 03; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 03.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Preoperative breast MRI for invasive ductal carcinoma with or without a DCIS component at needle biopsy: influence on surgical outcomes in the MIPA study.

Authors: Cozzi, Andrea Di Leo, Giovanni Houssami, Nehmat et al.

Source: European Radiology. Oct2025, Vol. 35 Issue 10, p6433-6443. 11p.

Subjects: Ductal carcinoma, Mastectomy, Reoperation, Computer-assisted image analysis (Medicine), Treatment effectiveness, Medical research, Carcinoma in situ

Immunotherapy innovations in triple-negative breast cancer: targeting checkpoints, combinations, and biomarkers.

Authors: Wang, Zi-Xin Chu, Ju-Hang Wang, Ya-Ru et al.

Source: Oncology Reviews. 2026, p1-12. 12p.

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Authors: Medford AJ Velimirovic M Gefen Y et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 212 (3), pp. 437-447. Date of Electronic Publication: 2025 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

ASO Author Reflections: Development of Natural Language Processing-Based Machine-Learning Algorithms to Identify Pathologic Complete Response from Surgical Pathology Reports.

Authors: Wu G Cheligeer C Xu Y

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Apr; Vol. 30 (4), pp. 2104-2105. Date of Electronic Publication: 2022 Dec 22.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Dismal pathological response to neoadjuvant chemotherapy in stage III breast cancer patients in Tanzania: A retrospective review.

Authors: Kivuyo, Nashivai Akoko, Larry Mutajwaha, John of God et al.

Source: PLoS ONE. 4/23/2025, Vol. 20 Issue 4, p1-10. 10p.

Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.

Authors: De Moura, Alexandre Gleizes, Orane Cabel, Luc et al.

Source: Scientific Reports. 11/7/2025, Vol. 15 Issue 1, p1-9. 9p.

Implementation of precision medicine in treating non-communicable diseases: a systematic review.

Authors: Liang, Shuang Kennedy, Elizabeth Gale, Nyree et al.

Source: Journal of Translational Medicine. 10/27/2025, Vol. 23 Issue 1, p1-14. 14p.

HOPA 2026 ABSTRACTS.

Source: Journal of Hematology Oncology Pharmacy. Mar2026, Vol. 16, p9-35. 26p.

ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis.

Authors: Burkbauer L Goldbach MM Tchou JC

Source: Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (13), pp. 8663-8664. Date of Electronic Publication: 2021 Jul 24.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Current landscape of sequencing ADCs in metastatic breast cancer.

Authors: McLaughlin S Ravani LV Moy B et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Dec 17; Vol. 17, pp. 17588359251396656. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.

Authors: Kantor O King TA

Source: Annals of surgical oncology [Ann Surg Oncol] 2021 Mar; Vol. 28 (3), pp. 1368-1369. Date of Electronic Publication: 2021 Jan 02.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Prognostic value of molecular and radiologic characteristics on dedicated breast [¹⁸F]FDG PET/MRI in breast cancer patients treated with neoadjuvant chemo(targeted) therapy: a retrospective cohort study.

Authors: Lenaerts, Melissa de Mooij, Cornelis M. Houwers, Janneke B. et al.

Source: EJNMMI Research. 12/5/2025, Vol. 16 Issue 1, p1-12. 12p.